Concepedia

Ralf Wilkowski

RW

Statistics

Publications

28

Citations

1.9K

H-Index

21

Active since

1996

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

Klinik und Poliklinik für Strahlentherapie und Radioonkologie

Zentralklinik Bad Berka

München Klinik

Ralf Wilkowski is an author at Ludwig-Maximilians-Universität München specializing in medicine, oncology, and radiation therapy.

Publications per year

1996–2011

28

Publications

28

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer

Volker Heinemann, D. Quietzsch, Frank Gieseler et al. · Journal of Clinical Oncology · 2006 · 684 citations

, , +13

Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer

Philipp Manegold, Carmen Paringer, Ulrike Kulka et al. · Clinical Cancer Research · 2008 · 108 citations

, , +16

Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone

E. Dühmke, Volker Diehl, Markus Loeffler et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 81 citations

, , +11

Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin?

P Stieber, A.M. Szymala, Andreas Schalhorn et al. · Oncology Research and Treatment · 2003 · 71 citations · Full text

, , +14

Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.

Ralf Wilkowski, Martin Thoma, Christiane J. Bruns et al. · PubMed · 2006 · 71 citations

, , +13

1–5 of 28